Cambio acquires Cayder amid renewed focus on UK and Ireland market

Cambio Healthcare has acquired Cayder under plans to increase its NHS footprint, boost revenues and earnings and help push the NHS agenda to digital.

Cayder will be integrated into Cambio’s UK business operation based in Reading with immediate effect.

Group CEO of Cambio Healthcare in Sweden, Pete Gille said: “Cayder is a good fit and complementary business.”

“We share a vision of improving patient care through innovative, cost effective technology and removing paper and inefficiency from the healthcare process.”

Gille said Cayder has healthy revenues, a strong pipeline, good technology, and talented people.

“Its patient flow and clinical solutions complement our own Cosmic clinical products and fit perfectly with our UK strategy to deliver electronic patient records against the government’s paperless targets and digital agenda.”

Cayder’s strong market presence, reputation and product acceptance were key considerations, according to its founder Stuart Rankin.

“The acquisition fits both Cayder and Cambio’s UK strategy and immediately creates a larger customer base and stronger UK market presence”, Rankin said.

“As an SME, we faced increasing pressure with protracted NHS procurement cycles. Joining forces gives all of us the ability to grow exponentially and scale quickly with a sustainable business model.”

This latest move follows the appointment last month of Adrian Stevens as Cambio’s UK and Ireland CEO as the company looks to grow its UK business.

Stevens said the UK’s vision of region-wide, fully integrated healthcare is a reality in Sweden, and has been for some time.

“My goal is to transfer this technology, knowledge and capability to the NHS through a proven, effective delivery strategy”.

Cayder is one of the UK’s main providers of solutions to manage the flow of patients through the care process.